Related Experiment Video
Updated: May 22, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Microfluidic approach to genotyping human platelet antigens
C Lim1, D P Manage, A Atrazhev
1Canadian Blood Services, Research and Development, Edmonton, Canada.
IET Nanobiotechnology
|May 8, 2012
Summary
Microfluidic chip technology offers a faster, more accessible method for blood group genotyping. This novel application shows high concordance with traditional methods, paving the way for integrated lab-on-a-chip blood typing solutions.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Genetics
Background:
- Conventional blood typing methods face challenges in cost, time, and accessibility.
- Microfluidic platforms, or 'lab-on-a-chip' devices, offer potential for streamlined diagnostics.
- Previous applications of microfluidics include bacterial and viral detection.
Purpose of the Study:
- To investigate blood group genotyping as a novel application for microfluidic technology.
- To demonstrate the feasibility of on-chip genotyping using a microfluidic platform.
- To compare microfluidic chip-based genotyping with conventional methods.
Main Methods:
- DNA purification using ChargeSwitch™ magnetic beads.
- Polymerase chain reaction (PCR) for DNA amplification.
- Restriction fragment length polymorphism (RFLP) and capillary electrophoresis (CE) on microfluidic chips for HPA-1 genotyping.
Main Results:
- Analysis of 19 blood donor specimens for the human platelet antigen 1 (HPA-1) genotype.
- Identified nine donors as HPA-1a/1a and ten as HPA-1a/1b.
- Achieved high concordance (all but one sample) between conventional and on-chip genotyping methods.
Conclusions:
- Microfluidic chip-based genotyping is a feasible and promising approach for blood group determination.
- The technology offers advantages in speed, reagent consumption, and potential for automation.
- Future development aims to integrate all genotyping steps onto a single microfluidic chip for complete blood group analysis.
